Humphrey, SP, Williamson, RT A review of saliva: Normal composition, flow, and function. Journal of Prosthetic Dentistry 2001 Feb; 85(2): 162–9.CrossRefGoogle ScholarPubMed

Affoo, RH, Foley, N, Garrick, R, Siqueira, WL, Martin, RE Meta-analysis of salivary flow rates in young and older adults. Journal of the American Geriatrics Society 2015; 63(10): 2142–51.Google Scholar

Affoo, RH, Foley, C, Garrick, R, Siquiera, WL, Martin, RE Meta-analysis of salivary flow rates in young and older adults. Journal of the American Geriatrics Society 2015; 63(10): 2142–51.Google Scholar

Mese, H, Matsuo, R. Salivary secretion, taste and hyposalivation. Journal of Oral Rehabilitation 2007; 34(10): 711–23.CrossRefGoogle ScholarPubMed

Nederfors, T. Xerostomia and hyposalivation. Advances in Dental Research 2000; 14: 48–56.Google Scholar

Castro, I, Sepúlveda, D, Cortés, J, Quest, AFG, Barrera, MJ, Bahamondes, V, et al. Oral dryness in Sjögren’s syndrome patients. Not just a question of water. Autoimmune Reviews. 2013; 12(5): 567–74.Google Scholar

Boros, I, Keszler, P. Sialorrhea: Hypersalivation and drooling. An underestimated problem in medical practice. Fogorvosi szemle 2006; 99(3): 99–108.Google Scholar

Zlotnik, Y, Balash, Y, Korczyn, AD, Giladi, N, Gurevich, T. Disorders of the oral cavity in Parkinson’s disease and parkinsonian syndromes. Parkinsons Disease 2015; 2015: 379482.Google Scholar

Dubow, JS Autonomic dysfunction in Parkinson’s disease. Disease a Month 2007; 53(5): 265–74.Google Scholar

Trocello, JM, Osmani, K, Pernon, M, Chevaillier, G, de Brugière, C, Remy, P, et al. Hypersialorrhea in Wilson’s disease. Dysphagia 2015; 30(5): 489–95.Google Scholar

ALS Association [Internet]. [cited 27 November 2016]. Available from: www.alsa.org/als-care/resources/publications-videos/factsheets/epidemiology.html.Google Scholar

Freudenreich, O. Drug-induced sialorrhea. Drugs of Today (Barcelona, Spain) (1998)2005; 41(6): 411–18.Google Scholar

Lakraj, AA, Moghimi, N, Jabbari, B. Sialorrhea: Anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins. Toxins 2013; 5(5): 1010–1031.Google Scholar

Kalf, JG, Bloem, BR, Munneke, M. Diurnal and nocturnal drooling in Parkinson’s disease. Journal of Neurology 2012; 259(1): 119–23.Google Scholar

Bagheri, H, Damase-Michel, C, Lapeyre-Mestre, M, Cismondo, S, O’Connell, D, Senard, JM, et al. A study of salivary secretion in Parkinson’s disease. Clinical Neuropharmacology 1999; 22(4): 213–15.Google Scholar

Johnston, BT, Li, Q, Castell, JA, Castell, DO Swallowing and esophageal function in Parkinson’s disease. American Journal of Gastroenterology 1995; 90(10): 1741–6.Google ScholarPubMed

Reeve, A, Simcox, E, Turnbull, D. Ageing and Parkinson’s disease: Why is advancing age the biggest risk factor? Ageing Research Reviews 2014;14: 19–30.Google Scholar

Scully, C. Drug effects on salivary glands: Dry mouth. Oral Diseases 2003;9(4): 165–76.Google Scholar

Cersosimo, MG, Raina, GB, Calandra, CR, Pellene, A, Gutiérrez, C, Micheli, FE, et al. Dry mouth: An overlooked autonomic symptom of Parkinson’s disease. Journal of Parkinson’s Disease 2011; 1(2): 169–73.Google Scholar

Cersósimo, MG, Tumilasci, OR, Raina, GB, Benarroch, EE, Cardoso, EM, Micheli, F, et al. Hyposialorrhea as an early manifestation of Parkinson disease. Autonomic Neuroscience 2009; 150(1–2): 150–1.Google Scholar

Del Tredici, K, Hawkes, CH, Ghebremedhin, E, Braak, H. Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson’s disease. Acta Neuropathologica. 2010; 119(6): 703–13.Google Scholar

Squires, N, Wills, A, Rowson, J. The management of drooling in adults with neurological conditions. Current Opinions in Otolaryngology Head and Neck Surgery 2012; 20(3): 171–6.Google ScholarPubMed

Dand, P, Sakel, M. The management of drooling in motor neurone disease. International Journal of Palliative Nursing. 2010; 16(11): 560–4.CrossRefGoogle ScholarPubMed

Meningaud, J-P, Pitak-Arnnop, P, Chikhani, L, Bertrand, J-C Drooling of saliva: A review of the etiology and management options. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics 2006; 101(1): 48–57.Google Scholar

Wolff, A, Fox, PC, Porter, S, Konttinen, YT Established and novel approaches for the management of hyposalivation and xerostomia. Current Pharmaceutical Design 2012; 18(34): 5515–21.Google Scholar

Furness, S, Worthington, HV, Bryan, G, Birchenough, S, McMillan, R. Interventions for the management of dry mouth: Topical therapies. Cochrane Database of Systematic Reviews 2011; 12: CD008934.Google Scholar

O’Sullivan, EM, Higginson, IJ Clinical effectiveness and safety of acupuncture in the treatment of irradiation-induced xerostomia in patients with head and neck cancer: A systematic review. Acupuncture Medicine 2010; 28(4): 191–9.Google Scholar

Furness, S, Bryan, G, McMillan, R, Birchenough, S, Worthington, HV Interventions for the management of dry mouth: Non-pharmacological interventions. Cochrane Database of Systematic Reviews 2013; 5: CD009603.Google Scholar

Hargitai, IA, Sherman, RG, Strother, JM The effects of electrostimulation on parotid saliva flow: A pilot study. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics 2005; 99(3): 316–20.Google Scholar

Strietzel, FP, Lafaurie, GI, Mendoza, GRB, Alajbeg, I, Pejda, S, Vuletić, L, et al. Efficacy and safety of an intraoral electrostimulation device for xerostomia relief: A multicenter, randomized trial. Arthritis and Rheumatology 2011; 63(1): 180–90.CrossRefGoogle ScholarPubMed

Wiseman, LR, Faulds, D. Oral pilocarpine: A review of its pharmacological properties and clinical potential in xerostomia. Drugs 1995; 49(1): 143–55.Google Scholar

Hunt, T. A double-blind, placebo-controlled, multiple-dose, tolerance and pharmacokinetic study of oral pilocarpine hydrochloride (HCL) in healthy male subjects. MGI Pharma. (Minneapolis) Data on File. 1993; 91–3.Google Scholar

Silvestre-Rangil, J, Silvestre, F-J, Puente-Sandoval, A, Requeni-Bernal, J, Simó-Ruiz, J-M Clinical-therapeutic management of drooling: Review and update. Oral Medicine and Pathology 2011; 16(6): e763–6.Google Scholar

Arvedson, J, Clark, H, Lazarus, C, Schooling, T, Frymark, T. The effects of oral-motor exercises on swallowing in children: An evidence-based systematic review. Developmental Medicine and Child Neurology 2010; 52(11): 1000–13.Google Scholar

Meningaud, J-P, Pitak-Arnnop, P, Chikhani, L, Bertrand, J-C Drooling of saliva: A review of the etiology and management options. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics 2006; 101(1): 48–57.Google Scholar

Dand, P, Sakel, M. The management of drooling in motor neurone disease. International Journal of Palliative Nursing 2010; 16(11): 560–4.Google Scholar

Hawkey, NM, Zaorsky, NG, Galloway, TJ The role of radiation therapy in the management of sialorrhea: A systematic review. Laryngoscope 2016; 126(1): 80–5.Google Scholar

Squires, N, Wills, A, Rowson, J. The management of drooling in adults with neurological conditions. Current Opinion on Otolaryngology and Head Neck Surgery 2012; 20(3): 171–6.Google Scholar

Lakraj, AA, Moghimi, N, Jabbari, B. Sialorrhea: Anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins. Toxins (Basel) 2013; 5(5): 1010–31.Google Scholar

Banfi, P, Ticozzi, N, Lax, A, Guidugli, GA, Nicolini, A, Silani, V. A review of options for treating sialorrhea in amyotrophic lateral sclerosis. Respiratory Care 2015; 60(3): 446–54.Google Scholar

Vashishta, R, Nguyen, SA, White, DR, Gillespie, MB Botulinum toxin for the treatment of sialorrhea: A meta-analysis. Otolaryngology and Head Neck Surgery 2013; 148(2): 191–6.Google Scholar

Young, CA, Ellis, C, Johnson, J, Sathasivam, S, Pih, N. Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis. Cochrane Database of Systematic Reviews 2011; 5: CD006981.Google Scholar

Lloret, SP, Nano, G, Carrosella, A, Gamzu, E, Merello, M. A double-blind, placebo-controlled, randomized, crossover pilot study of the safety and efficacy of multiple doses of intra-oral tropicamide films for the short-term relief of sialorrhea symptoms in Parkinson’s disease patients. Journal of Neurological Sciences 2011; 310(1–2): 248–50.Google Scholar

Hyson, HC, Johnson, AM, Jog, MS Sublingual atropine for sialorrhea secondary to parkinsonism: A pilot study. Movement Disorders 2002; 17(6): 1318–20.CrossRefGoogle ScholarPubMed

Meningaud, JP, Pitak-Arnnop, P, Chikhani, L, Bertrand, JC Drooling of saliva: A review of the etiology and management options. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics 2006; 101(1): 48–57.Google Scholar

Squires, N, Wills, A, Rowson, J. The management of drooling in adults with neurological conditions. Current Opinions in Otolaryngology Head Neck Surgery 2012; 20(3): 171–6.Google ScholarPubMed

De Simone, GG, Eisenchlas, JH, Junin, M, Pereyra, F, Brizuela, R. Atropine drops for drooling: A randomized controlled trial. Palliative Medicine 2006; 20(7): 665–71.Google Scholar

Reddihough, D, Erasmus, CE, Johnson, H, McKellar, GMW, Jongerius, PH, Cerebral Palsy Institute. Botulinum toxin assessment, intervention and aftercare for paediatric and adult drooling: International consensus statement. European Journal of Neurology 2010; 17 Suppl. 2: 109–21.Google Scholar

Arbouw, MEL, Movig, KLL, Koopmann, M, Poels, PJE, Guchelaar, H-J, Egberts, TCG, et al. Glycopyrrolate for sialorrhea in Parkinson disease: A randomized, double-blind, crossover trial. Neurology 2010; 74(15): 1203–7.Google Scholar

Strutt, R, Fardell, B, Chye, R. Nebulized glycopyrrolate for drooling in a motor neuron patient. Journal of Pain and Symptom Management 2002; 23(1): 2–3.Google Scholar